Filing Flows › TherapeuticsMD (TXMD) › Q2 2026 › vs Q2 2025
TherapeuticsMD (TXMD) Q2 2026 vs Q2 2025 (year over year)
TherapeuticsMD's revenue fell $83K (-9%) from $952K in Q2 2025 to $869K in Q2 2026.
TherapeuticsMD, Q2 2026: revenue $869K (-9% year over year), operating margin -93.9%, net earnings $155K, operating cash flow $779K. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $869K | $952K | −$83K | -9% |
| Other income, net | $980K | $1.2M | −$266K | -21% |
| Costs & expenses | $1.8M | $2.2M | −$349K | -16% |
| Operating costs | $1.7M | $1.6M | $38K | +2% |
| Income tax | $9K | $0 | $9K | — |
| Net earnings | $155K | $551K | −$396K | -72% |
| Other operating costs | $108K | $96K | $12K | +12% |
| Operating cash sources | $779K | $381K | $398K | +104% |
| Depreciation & amortization | $95K | $96K | −$1K | -1% |
| Share-based compensation | $4K | $1K | $3K | +300% |
| Working capital & other | $525K | −$267K | $792K | — |
| Operating cash flow | $779K | $381K | $398K | +104% |
Questions
How much did TherapeuticsMD's revenue grow year over year in Q2 2026?
TherapeuticsMD's revenue fell $83K (-9%) from $952K in Q2 2025 to $869K in Q2 2026.